27 related articles for article (PubMed ID: 23466061)
1. Diversity of cytogenetic and pathohistologic profiles in glioblastoma.
Hassler M; Seidl S; Fazeny-Doerner B; Preusser M; Hainfellner J; Rössler K; Prayer D; Marosi C
Cancer Genet Cytogenet; 2006 Apr; 166(1):46-55. PubMed ID: 16616111
[TBL] [Abstract][Full Text] [Related]
2. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
[TBL] [Abstract][Full Text] [Related]
3. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide.
Pojo M; Gonçalves CS; Xavier-Magalhães A; Oliveira AI; Gonçalves T; Correia S; Rodrigues AJ; Costa S; Pinto L; Pinto AA; Lopes JM; Reis RM; Rocha M; Sousa N; Costa BM
Oncotarget; 2015 Apr; 6(10):7657-74. PubMed ID: 25762636
[TBL] [Abstract][Full Text] [Related]
4. 'Go or grow': the key to the emergence of invasion in tumour progression?
Hatzikirou H; Basanta D; Simon M; Schaller K; Deutsch A
Math Med Biol; 2012 Mar; 29(1):49-65. PubMed ID: 20610469
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models.
Gonçalves CS; Xavier-Magalhães A; Pojo M; Oliveira AI; Correia S; Reis RM; Sousa N; Rocha M; Costa BM
Genom Data; 2015 Sep; 5():54-8. PubMed ID: 26484224
[TBL] [Abstract][Full Text] [Related]
6. Beyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic Events.
Martínez R
J Signal Transduct; 2012; 2012():519807. PubMed ID: 22778947
[TBL] [Abstract][Full Text] [Related]
7. Patterning Networks of Grade IV Glioblastoma on Silicon Chip
Mellor NG; Cheung SA; Michaux P; Firth J; Graham ES; Day BW; Unsworth CP
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083627
[TBL] [Abstract][Full Text] [Related]
8. Chaperone protein P4HB predicts temozolomide response and prognosis in malignant glioma.
Sun S; Kiang KM; Leung GK
Oncol Lett; 2022 Aug; 24(2):264. PubMed ID: 35765277
[TBL] [Abstract][Full Text] [Related]
9. Potential roles for Gfi1 in the pathogenesis and proliferation of glioma.
Huang H; Xiang Y; Su B; Xiong W; Zhang X
Med Hypotheses; 2013 May; 80(5):629-32. PubMed ID: 23466061
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
[TBL] [Abstract][Full Text] [Related]
11. Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas.
Ramakrishnan V; Kushwaha D; Koay DC; Reddy H; Mao Y; Zhou L; Ng K; Zinn P; Carter B; Chen CC
Cancer Biomark; 2011-2012; 10(3-4):185-93. PubMed ID: 22674304
[TBL] [Abstract][Full Text] [Related]
12. MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients.
Lakomy R; Sana J; Hankeova S; Fadrus P; Kren L; Lzicarova E; Svoboda M; Dolezelova H; Smrcka M; Vyzula R; Michalek J; Hajduch M; Slaby O
Cancer Sci; 2011 Dec; 102(12):2186-90. PubMed ID: 21895872
[TBL] [Abstract][Full Text] [Related]
13. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis.
Gonçalves CS; Xavier-Magalhães A; Martins EP; Pinto AA; Pires MM; Pinheiro C; Reis RM; Sousa N; Costa BM
Mol Oncol; 2020 Jun; 14(6):1224-1241. PubMed ID: 31923345
[TBL] [Abstract][Full Text] [Related]
14. Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents.
Szeliga M; Zgrzywa A; Obara-Michlewska M; Albrecht J
J Neurochem; 2012 Nov; 123(3):428-36. PubMed ID: 22888977
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
